143
Views
7
CrossRef citations to date
0
Altmetric
Patent Evaluations

Novel fluorine-containing DAPY derivatives as potent HIV-1 NNRTIs: a patent evaluation of WO2014072419

, , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xiaofang Zuo, Zhipeng Huo, Dongwei Kang, Gaochan Wu, Zhongxia Zhou, Xinyong Liu & Peng Zhan. (2018) Current insights into anti-HIV drug discovery and development: a review of recent patent literature (2014–2017). Expert Opinion on Therapeutic Patents 28:4, pages 299-316.
Read now

Articles from other publishers (6)

Sheng Han & Yiming Lu. (2023) Fluorine in anti-HIV drugs approved by FDA from 1981 to 2023. European Journal of Medicinal Chemistry 258, pages 115586.
Crossref
Shuang-Xi Gu, Jiong Chen, Yuan-Yuan Zhu, Wei Ming, Shuang-Shuang Zhang & Jin-Xu Cao. 2023. Privileged Scaffolds in Drug Discovery. Privileged Scaffolds in Drug Discovery 513 542 .
Ankur Kumar, Simranpreet K. Wahan, Sharma Arvind Virendra & Pooja A. Chawla. (2022) Recent Advances on the Role of Nitrogen‐Based Heterocyclic Scaffolds in Targeting HIV through Reverse Transcriptase Inhibition. ChemistrySelect 7:36.
Crossref
Vigneshwaran Namasivayam, Murugesan Vanangamudi, Victor G. Kramer, Sonali Kurup, Peng Zhan, Xinyong Liu, Jacob Kongsted & Siddappa N. Byrareddy. (2018) The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic. Journal of Medicinal Chemistry 62:10, pages 4851-4883.
Crossref
Shuang-Xi Gu, Huan-Huan Lu, Gen-Yan Liu, Xiu-Lian Ju & Yuan-Yuan Zhu. (2018) Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors. European Journal of Medicinal Chemistry 158, pages 371-392.
Crossref
Dongwei Kang, Zengjun Fang, Boshi Huang, Xueyi Lu, Heng Zhang, Haoran Xu, Zhipeng Huo, Zhongxia Zhou, Zhao Yu, Qing Meng, Gaochan Wu, Xiao Ding, Ye Tian, Dirk Daelemans, Erik De Clercq, Christophe Pannecouque, Peng Zhan & Xinyong Liu. (2017) Structure-Based Optimization of Thiophene[3,2- d ]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants . Journal of Medicinal Chemistry 60:10, pages 4424-4443.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.